| Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors R Ettari, E Nizi, ME Di Francesco, MA Dude, G Pradel, R Vicík, ... Journal of medicinal chemistry 51 (4), 988-996, 2008 | 237 | 2008 |
| Falcipain‐2 inhibitors R Ettari, F Bova, M Zappalà, S Grasso, N Micale Medicinal research reviews 30 (1), 136-167, 2010 | 154 | 2010 |
| BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis N Irrera, M Vaccaro, A Bitto, G Pallio, G Pizzino, M Lentini, V Arcoraci, ... Clinical Science 131 (6), 487-498, 2017 | 130 | 2017 |
| Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma R Ettari, M Zappalà, S Grasso, C Musolino, V Innao, A Allegra Pharmacology & Therapeutics 182, 176-192, 2018 | 101 | 2018 |
| Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents N Micale, AP Kozikowski, R Ettari, S Grasso, M Zappalà, JJ Jeong, ... Journal of medicinal chemistry 49 (11), 3064-3067, 2006 | 100 | 2006 |
| Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis R Ettari, L Tamborini, IC Angelo, N Micale, A Pinto, C De Micheli, P Conti Journal of Medicinal Chemistry 56 (14), 5637-5658, 2013 | 99 | 2013 |
| Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective falcipain-2 inhibitors R Ettari, N Micale, T Schirmeister, C Gelhaus, M Leippe, E Nizi, ... Journal of Medicinal Chemistry 52 (7), 2157-2160, 2009 | 92 | 2009 |
| Peptide‐based proteasome inhibitors in anticancer drug design N Micale, K Scarbaci, V Troiano, R Ettari, S Grasso, M Zappala Medicinal research reviews 34 (5), 1001-1069, 2014 | 66 | 2014 |
| Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors R Ettari, C Bonaccorso, N Micale, C Heindl, T Schirmeister, ML Calabrò, ... ChemMedChem 6 (7), 1228-1237, 2011 | 61 | 2011 |
| Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of Neglected Tropical Diseases (NTDs) S Previti, R Ettari, S Cosconati, G Amendola, K Chouchene, A Wagner, ... Journal of Medicinal Chemistry 60 (16), 6911-6923, 2017 | 57 | 2017 |
| The inhibition of cysteine proteases rhodesain and TbCatB: A valuable approach to treat Human African Trypanosomiasis R Ettari, S Previti, L Tamborini, G Cullia, S Grasso, M Zappalà Mini reviews in medicinal chemistry 16 (17), 1374-1391, 2016 | 56 | 2016 |
| Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors R Ettari, E Nizi, ME Di Francesco, N Micale, S Grasso, M Zappalà, R Vicík, ... ChemMedChem 3 (7), 1030-1033, 2008 | 52 | 2008 |
| Design and synthesis of novel isoxazole-based HDAC inhibitors P Conti, L Tamborini, A Pinto, L Sola, R Ettari, C Mercurio, C De Micheli European journal of medicinal chemistry 45 (9), 4331-4338, 2010 | 51 | 2010 |
| Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening G Amendola, R Ettari, S Previti, C Di Chio, A Messere, S Di Maro, ... Journal of Chemical Information and Modeling 61 (4), 2062-2073, 2021 | 47 | 2021 |
| Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases R Ettari, S Previti, A Bitto, S Grasso, M Zappala Current medicinal chemistry 23 (12), 1217-1238, 2016 | 46 | 2016 |
| Development of rhodesain inhibitors with a 3‐bromoisoxazoline warhead R Ettari, L Tamborini, IC Angelo, S Grasso, T Schirmeister, L Lo Presti, ... ChemMedChem 8 (12), 2070-2076, 2013 | 46 | 2013 |
| Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain R Ettari, M Zappalà, N Micale, T Schirmeister, C Gelhaus, M Leippe, ... European journal of medicinal chemistry 45 (7), 3228-3233, 2010 | 46 | 2010 |
| Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors N Micale, R Ettari, T Schirmeister, A Evers, C Gelhaus, M Leippe, ... Bioorganic & medicinal chemistry 17 (18), 6505-6511, 2009 | 43 | 2009 |
| Development of peptidomimetic boronates as proteasome inhibitors N Micale, R Ettari, A Lavecchia, C Di Giovanni, K Scarbaci, V Troiano, ... European journal of medicinal chemistry 64, 23-34, 2013 | 42 | 2013 |
| Formaldehyde exposure and acute myeloid leukemia: a review of the literature A Allegra, G Spatari, S Mattioli, S Curti, V Innao, R Ettari, AG Allegra, ... Medicina 55 (10), 638, 2019 | 41 | 2019 |
